Literature DB >> 31411356

The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation.

Hann-Hsiang Chao1, Caitlin A Schonewolf1, Erik X Tan1, Samuel Swisher-McClure1, Alireza F Ghiam1, Gregory S Weinstein2, Bert W O'Malley2, Ara A Chalian2, Christopher H Rassekh2, Jason G Newman2, Roger B Cohen3, Joshua M Bauml3, Charu Aggarwal3, Alexander Lin1, John N Lukens1.   

Abstract

BACKGROUND: For patients with head and neck squamous cell carcinoma (SCC) undergoing surgery followed by postoperative radiotherapy (PORT), time from surgery to completion of adjuvant therapy, "package time" impacts locoregional control (LRC). However, the significance of package time in HPV+ oropharyngeal SCC (OPSCC) is unknown.
METHODS: We examined patients undergoing TORS resection with PORT for HPV+ OPSCC from January 2010 to December 2015 with ≥18 months follow-up (n = 267). A cutoff of 15 weeks was used to delineate patients into short and long package time groups. LRC loss was defined as any recurrence after surgery.
RESULTS: Prolonged package time >15 weeks was associated with inferior LRC in this HPV+ OPSCC cohort, driven primarily by interval from surgery to PORT initiation. Multivariate analysis showed that package time and T classification are both independently associated with LRC.
CONCLUSIONS: Among HPV+ OPSCC, prolongation of package time appears to compromise LRC, but not survival.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  HPV-related oropharyngeal squamous cell carcinoma; head and neck cancer; package time; treatment duration

Mesh:

Year:  2019        PMID: 31411356     DOI: 10.1002/hed.25914

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.

Authors:  Dylan A Levy; Hong Li; Katherine R Sterba; Chanita Hughes-Halbert; Graham W Warren; Brian Nussenbaum; Anthony J Alberg; Terry A Day; Evan M Graboyes
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.